Cue Biopharma, Inc. (FRA:1UC)

Cue Biopharma Statistics

Total Valuation

Cue Biopharma has a market cap or net worth of EUR 40.30 million. The enterprise value is 28.05 million.

Market Cap	40.30M
Enterprise Value	28.05M

Important Dates

The last earnings date was Wednesday, November 19, 2025.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	78.74M
Shares Outstanding	n/a
Shares Change (YoY)	+74.30%
Shares Change (QoQ)	+5.67%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	24.33%
Float	78.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.66
PB Ratio	3.57
P/TBV Ratio	3.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.87
EV / Sales	4.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.10

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.47.

Current Ratio	1.66
Quick Ratio	1.46
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	-0.21
Interest Coverage	-83.02

Financial Efficiency

Return on equity (ROE) is -195.19% and return on invested capital (ROIC) is -87.73%.

Return on Equity (ROE)	-195.19%
Return on Assets (ROA)	-62.31%
Return on Invested Capital (ROIC)	-87.73%
Return on Capital Employed (ROCE)	-236.40%
Revenue Per Employee	147,593
Profits Per Employee	-783,347
Employee Count	41
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.77%
50-Day Moving Average	0.60
200-Day Moving Average	0.68
Relative Strength Index (RSI)	46.86
Average Volume (20 Days)	182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.91

Income Statement

In the last 12 months, Cue Biopharma had revenue of EUR 6.05 million and -32.12 million in losses. Loss per share was -0.37.

Revenue	6.05M
Gross Profit	-24.14M
Operating Income	-32.48M
Pretax Income	-32.12M
Net Income	-32.12M
EBITDA	-32.16M
EBIT	-32.48M
Loss Per Share	-0.37

Balance Sheet

The company has 17.40 million in cash and 5.26 million in debt, giving a net cash position of 12.14 million.

Cash & Cash Equivalents	17.40M
Total Debt	5.26M
Net Cash	12.14M
Net Cash Per Share	n/a
Equity (Book Value)	11.29M
Book Value Per Share	0.15
Working Capital	8.77M

Cash Flow

In the last 12 months, operating cash flow was -25.26 million and capital expenditures -152,562, giving a free cash flow of -25.41 million.

Operating Cash Flow	-25.26M
Capital Expenditures	-152,562
Free Cash Flow	-25.41M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-536.73%
Pretax Margin	-530.75%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cue Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.30%
Shareholder Yield	-74.30%
Earnings Yield	-79.70%
FCF Yield	-63.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cue Biopharma has an Altman Z-Score of -17.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.56
Piotroski F-Score	2